REFERENCES
1. Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 2020;8:e191-203.
2. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49.
3. World Health Organization (WHO). Global health estimates: life expectancy and leading causes of death and disability. WHO; 2020. Accessed from: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates [Last accessed on 6 Sep 2023].
4. Choi S, Ismail A, Pappas-Gogos G, Boussios S. HPV and cervical cancer: a review of epidemiology and screening uptake in the UK. Pathogens 2023;12:298.
5. Aimagambetova G, Azizan A. Epidemiology of HPV infection and HPV-related cancers in kazakhstan: a review. Asian Pac J Cancer Prev 2018;19:1175-80.
6. Brisson M, Kim JJ, Canfell K, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet 2020;395:575-90.
7. Bruni L, Albero G, Serrano B, et al. Human papillomavirus and related diseases in Kazakhstan. Summary report. Inf Cent HPV Cancer 2019. Available from: https://hpvcentre.net/statistics/reports/KAZ.pdf [Last accessed on 6 Sep 2023].
8. Bruni L, Albero G, Serrano B, et al. ICO/IARC information centre on HPV and cancer (HPV information centre). Human papillomavirus and related diseases in the world. Summary report 10 March 2023. Available from: https://hpvcentre.net/statistics/reports/XWX.pdf [Last accessed on 6 Sep 2023].
9. Aimagambetova G, Chan CK, Ukybassova T, et al. Cervical cancer screening and prevention in Kazakhstan and central Asia. J Med Screen 2021;28:48-50.
10. Saraiya M, Unger ER, Thompson TD, et al. HPV Typing of Cancers Workgroup. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst 2015;107:djv086.
11. Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol 2018;47:14-26.
12. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50. Available from: https://www.nature.com/articles/nrc798 [Last accessed on 24 Aug 2023].
13. Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination-review of current perspectives. J Oncol 2019;2019:3257939.
14. Adcock R, Cuzick J, Hunt WC, McDonald RM, Wheeler CM; New Mexico HPV Pap Registry Steering Committee. Role of HPV genotype, multiple infections, and viral load on the risk of high-grade cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2019;28:1816-24.
15. Aimagambetova G, Babi A, Issanov A, et al. The distribution and prevalence of high-risk HPV genotypes other than HPV-16 and HPV-18 among women attending gynecologists’ offices in Kazakhstan. Biology 2021;10:794.
16. Fowler JR, Maani EV, Dunton CJ, Jack BW. Cervical cancer. In: StatPearls. Treasure Island, FL: StatPearls; 2022.
17. Kombe Kombe AJ, Li B, Zahid A, et al. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front Public Health 2020;8:552028.
18. Li X, Xiang F, Dai J, et al. Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China. Virol J 2022;19:146.
19. de Sanjose S, Quint WG, Alemany L, et al.; Retrospective international survey and HPV time trends study group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010;11:1048-56.
20. Bekmukhambetov YZ, Balmagambetova SK, Jarkenov TA, Nurtayeva SM, Mukashev TZ, Koyshybaev AK. Distribution of high risk human papillomavirus types in western Kazakhstan - retrospective analysis of PCR data. Asian Pac J Cancer Prev 2016;17:2667-72. Available from: https://journal.waocp.org/article_32456.html [Last accessed on 24 Aug 2023].
21. Niyazmetova L, Aimagambetova G, Stambekova N, Abugalieva, Z, Seksembayeva K, Ali S, Azizan A. Application of molecular genotyping to determine prevalence of HPV strains in pap smears of Kazakhstan women. Int J Infect Dis 2017;54:85-8.
22. Aimagambetova G, Chan CK, Ukybassova T, Imankulova B, Balykov A, Kongrtay K, Azizan A. Cervical cancer screening and prevention in Kazakhstan and central Asia. J Med Screen 2020;28:48-50.
23. Bolatbekova R, Kaidarova D, Dushimova Z, et al. Prevalence of HPV and cytological abnormalities in young women in Almaty, Kazakhstan. J Clin Oncol 2022;40:e22503.
24. Babi A, Issa T, Issanov A, et al. Prevalence of high-risk human papillomavirus infection among Kazakhstani women attending gynecological outpatient clinics. Int J Infect Dis 2021;109:8-16.
25. Balmagambetova S, Gabutti G, Koyshybaev A, et al. Cervical screening in western Kazakhstan: liquid-based cytology "cell scan" versus azur-eosin staining. J Med Screen 2020;27:90-5.
26. Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K. Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet 2012;285:771-7.
27. Guo J, Guo S, Dong S. Efficacy, immunogenicity and safety of HPV vaccination in Chinese population: a meta-analysis. Front Public Health 2023;11:1128717.
28. Nah EH, Cho S, Kim S, Cho HI. Human papillomavirus genotype distribution among 18,815 women in 13 Korean cities and relationship with cervical cytology findings. Ann Lab Med 2017;37:426-33.
29. Bao YP, Li N, Smith JS, Qiao YL; ACCPAB members. Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 2008;18:71-9. Available from: https://ijgc.bmj.com/content/18/1/71.abstract [Last accessed on 8 Sep 2023].
30. Ren X, Hao Y, Wu B, et al. Efficacy of prophylactic human papillomavirus vaccines on cervical cancer among the Asian population: a meta-analysis. Front Microbiol 2022;13:1052324.
31. Liao L, Cheng H, Zeng F, Zhou W, Ding Y. Prevalence and distribution of human papillomavirus genotypes among women with high-grade squamous intraepithelial lesion and invasive cervical cancer in Ganzhou, China. J Clin Lab Anal 2019;33:e22708.
32. Kim MA, Han GH, Kim JH, Seo K. Current status of human papillomavirus infection and introduction of vaccination to the national immunization program in Korea: an overview. J Korean Med Sci 2018;33:e331.
33. Liu Y, Ang Q, Wu H, et al. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019. Virol J 2020;17:104.
34. Li L, Jiang M, Li T, et al. Absolute risk and attributable fraction of type-specific human papillomavirus in cervical cancer and precancerous lesions-a population-based study of 6286 women in rural areas of China. J Clin Med 2022;11:6483.
35. Xia C, Li S, Long T, Chen Z, Chan PKS, Boon SS. Current updates on cancer-causing types of human papillomaviruses (HPVs) in east, southeast, and south Asia. Cancers 2021;13:2691.
36. Wang J, Tang D, Wang K, et al. HPV genotype prevalence and distribution during 2009-2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination. BMC Womens Health 2019;19:90.
37. Ebrahimi N, Yousefi Z, Khosravi G, et al. Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective. Front Immunol 2023;14:1150238.
38. Dassi L, Annunziata C, Botti C, et al. Detection of human papillomaviruses in the nasopharynx of breastfed infants: new findings and meta-analysis. Viruses 2020;12:1119.
39. Isaguliants M, Krasnyak S, Smirnova O, Colonna V, Apolikhin O, Buonaguro FM. Genetic instability and anti-HPV immune response as drivers of infertility associated with HPV infection. Infect Agent Cancer 2021;16:29.
40. Junerbayeva GM, Kurmanov ZhB, Kulmagambetova AZh, Uralbayeva AM. Epidemiology of human papillomavirus in women of Aktobe region. Exploratory analysis of cross-sectional survey data. West Kaz Med J 2015;4:49-52. Available from: https://cyberleninka.ru/article/n/epidemiologiya-virusa-papillomy-cheloveka-u-zhenschin-aktyubinskoy-oblasti/viewer [Last accessed on 6 Sep 2023].
41. Robadi IA, Pharaon M, Ducatman BS. The importance of high-risk human papillomavirus types other than 16 and 18 in cervical neoplasia. Arch Pathol Lab Med 2018;142:693-5.
42. Aimagambetova G, Babi A, Issa T, Issanov A. What factors are associated with attitudes towards HPV vaccination among Kazakhstani women? Exploratory analysis of cross-sectional survey data. Vaccine 2022;10:824.
43. Akhatova A, Azizan A, Atageldiyeva K, et al. Prophylactic human papillomavirus vaccination: from the origin to the current state. Vaccine 2022;10:1912.
44. Babi A, Issa T, Issanov A, et al. Knowledge and attitudes of mothers toward HPV vaccination: a cross-sectional study in Kazakhstan. Womens Health 2023;19:17455057231172355.
45. Imankulova B, Babi A, Issa T, et al. Prevalence of precancerous cervical lesions among nonvaccinated kazakhstani women: the national tertiary care hospital screening data (2018). Healthcare 2023;11:235.
46. Issanov A, Karim ME, Aimagambetova G, Dummer TJB. Does vaccination protect against human papillomavirus-related cancers? Preliminary findings from the United States national health and nutrition examination survey (2011 - 2018). Vaccine 2022;10:2113.
